Taylor,
T.C.J.:
—These
are
appeals
heard
in
Toronto,
Ontario,
on
September
1,
1989
and
November
3,
1989
against
income
tax
assessments
for
the
years
1983,
1984
and
1985
in
which
dividends
received
by
the
appellant
in
the
amounts
of
$51,000,
$27,750
and
$51,750
respectively,
were
reported
as
income
of
the
appellant's
wife,
Mrs.
Sullivan.
The
appellant's
position
was
that
by
virtue
of
subsection
74(1)
of
the
Income
Tax
Act,
R.S.C.
1952,
c.
148
(am.
S.C.
1970-71-72,
c.
63)
(the
"Act"),
the
dividend
income
at
issue
must
be
reported
as
that
of
Mrs.
Sullivan,
and
could
not
be
regarded
as
income
to
him.
Because
of
the
unusual
nature
of
this
matter
I
will
quote
extensively
from
the
notice
of
appeal
and
the
reply
to
the
notice
of
appeal.
For
the
appellant:
-
In
May
1983,
Mrs.
Joan
Sullivan,
the
taxpayer's
spouse,
caused
a
corporation,
551360
Ontario
Ltd.,
to
be
formed.
-
On
May
12,
1983,
Mrs.
Sullivan
subscribed
and
paid
for
1,000
common
shares
for
$1,000.
These
shares
were
issued
to
Mrs.
Sullivan
on
May
12,
1983.
-
On
May
16,
1983,
Mrs.
Sullivan,
under
an
agreement
entered
into
on
that
date,
sold
her
1,000
shares
in
551360
Ontario
Ltd.
to
the
taxpayer
for
$1,000,
which
amount
was
paid
by
the
taxpayer
on
that
date.
-
On
May
19,
1983,
the
taxpayer
entered
into
an
agreement
with
551360
Ontario
Ltd.,
under
the
terms
of
which
all
the
issued
shares
of
Hugh
Sullivan
Drugs
Ltd.,
which
were
owned
by
the
taxpayer,
were
sold
to
551360
Ontario
Ltd.
Among
other
things,
this
agreement
provided
as
follows:
-
That
the
shares
were
to
be
sold
for
their
fair
market
value
at
the
effective
date
of
the
agreement.
-
That
the
purchase
Price
of
the
shares
was
to
be
paid
by
the
issue
of
1,000
common
shares
of
551360
Ontario
Ltd.
with
an
aggregate
paid-up
capital
of
$52.98.
-
That
any
difference
between
the
purchase
price
of
the
shares
of
Hugh
Sullivan
Drugs
Ltd.
and
the
specified
consideration
of
$52.98
in
shares
of
551360
Ontario
Ltd.
was
to
be
recorded
on
the
books
of
551360
Ontario
Ltd.
as
contributed
surplus.
-
That
the
Vendor
and
Purchaser
would
jointly
elect
and
file
an
election
under
Section
85
of
the
Income
Tax
Act.
-
The
fair
market
value
of
the
shares
of
Hugh
Sullivan
Drugs
Ltd.
at
the
time
of
the
transaction
was
calculated
to
be
$900,000.
-
The
Vendor
and
Purchaser
jointly
elected
under
Section
85
of
the
Income
Tax
Act
that
the
proceeds
of
disposition
of
the
shares
to
the
Vendor
and
the
cost
of
the
shares
be
deemed
to
be
$170,000,
an
amount
thought
to
be
equal
to
the
adjusted
cost
base
of
the
shares
to
the
Vendor.
It
was
discovered
later
that
the
amount
did
not
represent
the
adjusted
cost
base
of
the
shares,
since
certain
tax-free
dividends
had
not
been
allowed
for.
The
elected
amount
was
changed,
with
the
agreement
of
Revenue
Canada,
to
$128,642.
For
the
respondent:
-
at
the
time
of
incorporation
of
551360
Ontario
Ltd.
on
May
12,
1983,
Mrs.
Joan
Sullivan,
the
appellant's
spouse,
was
the
sole
shareholder
and
director
of
this
corporation;
-
as
of
the
date
of
the
sale
of
the
1000
shares
of
shares
of
551360
Ontario
Ltd.
sold
by
the
appellant's
spouse
to
the
appellant,
the
fair
market
value
of
those
shares
was
$1,000;
-
Joan
Sullivan,
the
appellant's
spouse,
incorporated
551360
Ontario
Ltd.
on
behalf
and
for
the
benefit
of
the
appellant
and
acted
as
agent
for
him
in
this
regard;
-
on
May
24,
1983,
Hugh
Sullivan
Drugs
Ltd.
declared
a
dividend
in
the
amount
of
$660,000
in
favour
of
551360
Ontario
Ltd.,
its
sole
shareholder;
-
on
May
31,
1984,
Hugh
Sullivan
Drugs
Ltd.
declared
a
dividend
in
the
amount
of
$132,000
in
favour
of
551360
Ontario
Ltd.,
its
sole
shareholder;
-
the
three
dividends
in
question
declared
by
551360
Ontario
Ltd.
in
1983,
1984
and
1985
were
made
possible
only
by
the
dividends
it
had
received
from
Hugh
Sullivan
Drugs
Ltd.
-
The
respondent
relies,
inter
alia,
upon
the
provisions
of
sections
3,
82
and
85,
paragraph
12(1)(j)
and
subsection
74(1)
of
the
Income
Tax
Act,
R.S.C.
1952,
Chapter
148,
as
amended,
(the
"Act")
applicable
to
the
1983,1984
and
1985
taxation
years
of
the
appellant
and
subsection
44(4)
of
the
Ontario
Business
Corporations
Act,
R.S.O.
1980,
chapter
54.
Evidence
Counsel
for
the
appellant
put
in
full
and
complete
testimony
and
evidence—and
there
was
little
if
any
dispute
regarding
the
basic
facts,
although
some
points
which
will
be
highlighted
later
arose
out
of
the
testimony
of
the
legal
and
accounting
advisors
to
the
appellant.
Some
of
the
basic
data
used
to
support
the
position
of
the
appellant
is
reproduced
hereunder
and
entitled
"Schedules":
Schedule
A
(Exhibit
A-1
at
the
hearing)
|
|
Ownership
of
Companies
|
|
1.
As
of
May
12,
1983
|
|
Hugh
Sullivan
|
Joan
Sullivan
|
5001
common
shares
|
1,000
common
shares
|
Hugh
Sullivan
Drugs
Ltd.
|
551360
Ontario
Ltd.
|
2.
As
of
May
16,
1983-Giving
Effect
To
Agreement
|
|
Between
Nancy
Joan
Sullivan
and
Hugh
Sullivan
|
|
Hugh
Sullivan
|
Hugh
Sullivan
|
5,001
common
shares
|
1,000
common
shares
|
Hugh
Sullivan
Drugs
Ltd.
|
551360
Ontario
Ltd.
|
3.
As
of
May
19,
1983
and
Thereafter-Giving
Effect
to
|
|
Agreement
of
May
19,
1983
|
|
Hugh
Sullivan
|
|
2,000
common
shares
|
|
551360
Ontario
Ltd.
|
|
5,001
common
shares
|
|
Hugh
Sullivan
Drugs
Ltd.
|
|
Schedule
B
(the
financial
statements
of
Hugh
Sullivan
Drugs
Ltd.
as
at
May
31,
1983,
Exhibit
A-5):
Retained
Earnings
—beginning
of
year
|
$744,037
|
Less:
Dividends
paid
on
common
shares
660,000
|
|
Retained
Earnings—end
of
year
|
84,037
|
Schedule
C
(the
financial
statements
of
551360
Ontario
Ltd.
for
the
year
ending
May
31,
1983
(first
year)
Exhibit
A-6):
551360
Ontario
Ltd.
Balance
Sheet
at
31st
May
1983
Assets
Current
Cash
$
998
Term
Deposits
and
guaranteed
investment
certificates
523,000
Accrued
interest
receivable
17,029
Loan
receivable—Hugh
Sullivan
Drugs
Ltd.
53,353
594,380
Long
Term
Investments
Notes
1
(a)
and
2
84,090
$678,470
Liabilities
and
Shareholder's
Equity
Current
Advances
from
shareholder
$
355
Income
taxes
payable
345
700
Shareholder's
Equity
Share
capital
Authorized
1,000,000
common
shares
of
no
par
value
1,000,000
redeemable
preference
shares
with
a
par
value
of
$1
each
4,000,000
participating
special
shares
of
no
par
value
Issued
in
the
period
1,000
common
shares
for
cash
$
1,000
1,000
common
shares
in
exchange
for
53
For
the
Period
From
Inception
12th
May
1983
to
31st
May
1983
551360
Ontario
Ltd.
Notes
To
Financial
Statements
At
31st
May
1983
|
1,053
|
Contributed
surplus—Note
3
|
676,037
|
Retained
earnings
|
|
Net
income
for
the
period
|
680
|
|
677,770
|
|
$678,470
|
551360
Ontario
Ltd.
|
|
Statement
of
Earnings
|
|
Income
|
|
Interest
|
$
1,027
|
Expenses
|
|
Bank
charges
|
|
2
|
|
1,025
|
Income
Taxes
|
|
345
|
Net
Income
For
the
Period
|
$
|
680
|
1.
Accounting
Policies
|
|
Long
term
investments
are
accounted
for
on
the
equity
basis.
|
|
2.
Long
Term
Investments
|
|
5,001
common
shares
of
Hugh
Sullivan
Drugs
Ltd.
|
744,090
|
Add:
Earnings
since
acquisition
|
—
|
|
744,090
|
Less:
Dividends
received
|
$660,000
|
|
$
84,090
|
3.
Contributed
Surplus
|
|
Net
book
value
of
underlying
assets
|
|
acquired
on
issue
of
common
shares
for
|
|
the
common
shares
of
Hugh
Sullivan
Drugs
Ltd.
|
$744,037
|
Less:
Dividends
paid
in
the
period
on
common
shares
|
68,000
|
Balance,
31st
May
1983
|
$676,037
|
On
Exhibit
A-7,
(the
required
election
form
under
section
85
of
the
Act),
the
following
is
recorded:
Date
of
Sale
or
Transfer:
May
20,
1983
Property
Disposed
of:
Description:
5,001
common
shares
Hugh
Sullivan
Drugs
Ltd.
Fair
Market
Value
at
time
of
disposition:
$900,000
Consideration
Received:
Description:
1,000
shares
of
551360
Ontario
Ltd.
Fair
Market
Value
(See
"Note"):
Nil
Agreed
Amount:
*170,000
The
agreed
amount
is
intended
to
be
the
"cost
amount”
of
properties
for
tax
purposes.
Testimony
regarding
the
above
financial
data
presented
to
the
Court
established
to
my
satisfaction
that:
(a)
the
amount
of
$53
shown
on
the
balance
sheet
of
551360
for
the
second
1,000
shares
of
551360
issued
to
Mr.
Sullivan
was
a
reference
to
the
value
at
which
the
5,001
common
shares
of
Drugs
had
been
shown
on
the
books
of
Drugs
before
transfer
of
those
shares
by
Mr.
Sullivan
to
551360;
(b)
the
551360
statement
of
earnings
above
did
not
include
the
$660,000
dividends
from
Drugs
as
part
of
income,
it
appeared
as
a
deduction
from
"long-term
investments";
(c)
from
the
"Notes
to
financial
statements
of
551360”,
the
$744,090
shown
under
“long
term
investments"
was
calculated
by
adding
together
the
$53
share
capital
in
Drugs
and
the
$744,037
retained
earnings
in
Drugs—before
payment
of
the
dividends
of
$660,000;
(d)
contrary
to
Note
3
to
the
financial
statements
of
551360,
reproduced
again
below,
the
"contributed
surplus"
was
not
the
result
of
"underlying
assets"
that
had
actually
been
acquired
in
the
common
share
exchange
covered
by
the
section
85
rollover.
The
assets
transferred
from
Drugs
to
551360
had
been
the
method
by
which
payment
had
been
made
for
the
dividends
declared
by
Drugs
after
the
section
85
rollover
had
been
completed,
according
to
the
appellant:
3.
Contributed
Surplus
Net
book
value
of
underlying
assets
acquired
on
issue
of
common
shares
for
the
common
shares
of
Hugh
Sullivan
Drugs
Ltd.
|
$744,037
|
As
I
understand
the
explanatory
testimony,
the
differences
in
the
recording
of
the
events
and
transactions
at
issue,
particularly
(d)
above,
as
contrasted
with
those
which
actually
occurred,
came
about
in
large
measure
in
an
effort
by
Mr.
Sullivan’s
advisors
to
make
the
intricate
steps
in
the
process
more
understandable
to
Mr.
Sullivan.
This
part
of
the
recording
of
the
events
may
have
served
to
make
somewhat
more
difficult
the
task
of
following
the
transactions,
but
it
remains
for
the
Court
to
examine
the
transactions
and
events
for
what
actually
did
happen.
I
also
note
for
the
record
that
in
Exhibit
A-6
(above)
the
value
of
$53
was
assigned
to
the
5,001
shares
of
Drugs,
but
I
am
not
aware
of
any
reason
that
it
could
not
have
been,
indeed
why
it
should
not
have
been
shown
as
"nil"
to
correspond
with
Exhibit
A-7,
other
than
the
attempts
of
the
appellant's
advisors
to
make
the
transactions
more
understandable
to
Mr.
Sullivan.
But
the
difference
in
those
two
amounts—"nil"
and
"$53"
is
irrelevant
for
purposes
of
this
appeal.
Equally,
shown
on
Exhibit
A-7
(above)
is
"Agreed
amount
$170,000”,
which
represented
the
"cost
amount"
of
the
properties
for
tax
purposes.
That
amount
does
not
enter
directly
into
this
appeal
either,
since
it
has
to
do
in
large
measure,
as
I
understand
it,
with
what
might
be
described
as
the
“V-day
value”
of
the
property
transferred.
Without
trying
to
be
too
specific
or
definitive
about
it
(since
it
does
not
enter
into
these
proceedings)
the
appellant
is
saying
that
the
5,001
shares
of
Drugs
had
a
V-day
value
of
$170,000.
I
am
aware
that
amount
was
later
adjusted
by
agreement
between
the
parties,
but
that
also
is
irrelevant
for
my
purposes.
Argument
I
would
quote
briefly
from
the
arguments
presented
on
behalf
of
the
appellant:
The
Respondent,
in
his
Reply,
has
submitted
that
subsection
74(1)
does
not
apply
in
the
circumstances
before
the
Court.
The
principal
reason
he
has
given
for
this
non-application
is
that—and
I
quote—"Since
she"—referring
to
Mrs.
Sullivan
—
"incorporated
551360
Ontario
Ltd.
and
acquired
1,000
shares
in
that
corporation
for
the
benefit
of.
.
.and
the
Appellant”.
It
is
the
Appellant's
position
that
no
principal
agent
relationship
existed
with
respect
to
any
part
of
the
transactions
in
question.
The
Respondent
has
also
submitted
that
the
dividends
paid
on
the
shares
of
551360
Ontario
Ltd.,
that
these
dividends
were
not
income
from
the
shares
of
551360
Ontario
Ltd.,
rather
the
Respondent
argues
the
dividends
were
income
from
the
shares
of
Hugh
Sullivan
Drugs
Ltd.
This
argument,
looking
to
the
underlying
source
of
the
income
for
the
purpose
of
characterizing
the
nature
of
the
dividends,
I
submit
is
not
supported.
The
Act
does
not
provide
a
workable
definition
of
"dividend";
we
must
take
the
ordinary
meaning
of
it
which
has
been
established
by
the
cases
to
be
a
ratable
distribution
other
than
a
step
in
the
reduction
of
capital.
The
scheme
of
the
Act,
I
suggest,
makes
it
clear
that
the
source
of
income
underlying
the
dividend
is
irrelevant
in
determining
the
treatment
of
the
dividend
for
tax
purposes.
In
paragraph
8
of
the
Reply,
the
Respondent
argues
in
the
alternative
that
the
dividends
were
not
income
from
the
first
1,000
shares
issued
to
Mrs.
Sullivan
but
were
income
from
the
second
1,000
shares
only.
Again
this
argument,
I
submit,
is
not
supported.
All
of
the
2,000
shared
outstanding
at
the
time
of
payment
of
the
dividends
were
shares
of
the
same
class,
that
is
common
shares,
all
were
owned
by
Mr.
Sullivan
and
the
dividends
were
declared
on
all
the
shares
of
that
class.
In
common
law
there
is
a
presumption
that,
in
the
absence
of
applicable
restrictions
in
the
articles
of
incorporation,
all
shareholders
entitled
to
dividends
on
the
shares
they
hold
equally
with
every
other
shareholder.
There
is
no
provision
in
the
articles
of
this
company
which
would
permit
such
a
differentiation
between
two
blocks
of
shares
of
the
same
class,.
.
.
.
Another
argument
was
made
by
the
Respondent
in
paragraph
9
of
his
Reply.
In
this
case,
the
Respondent
argues
that
the
property
that
was
the
original
shares
issued
to
Mrs.
Sullivan,
that
is,
the
1,000
shares,
being
the
shares
she
took
on
incorporation
and
those
that
she
received
by
resolution
immediately
after
were
somehow
different
from
the
shares
subsequently
held
by
Mr.
Sullivan,
because
the
transfer
of
shares—apparently
because
the
transfer
of
shares
of
the
operating
company
had
resulted
in
an
increase
in
the
value
of
the
shares
of
the
numbered
company.
It's
clear
that
such
an
increase
in
value
did
take
place,
obviously
can't
be
disputed.
The
shares
themselves,
however,
had
changed
in
no
way.
Their
legal
attributes
had
not
changed;
they
had
not
changed
in
form
nor
in
substance
but
only
in
value.
So,
the
shares
were
the
same
shares
although
clearly
affected
by
the
transactions
that
took
place.
Finally,
the
Respondent
argues
the
taxpayer
has
attempted
to
do
indirectly
that
which
he
cannot
do
directly,
that
is,
split
income
with
his
spouse.
The
taxpayer
doesn't
deny—in
fact
it’s
been
quite
readily
admitted—that
the
purpose
of
this
transaction
was
not
a
business
purpose,
that
is,
there
was
no
intention
that
the
holding
company
carry
on
a
business
or
any
particular
venture.
Although
that
could
clearly
happen
in
the
future
that
was
not
in
minds
of
the
people
forming
the
company
at
the
time
it
was
formed.
And
the
taxpayer
does
not
deny
that
the
particular
form
this
transaction
took,
that
is,
the
issue
of
shares
to
the
wife
and
the
subsequent
transfer
to
her
husband
does
not
deny
that
splitting
of
income
is
the
result
and
was
the
result
aimed
for
in
this
transaction.
What
he
does
deny,
however,
is
that
this
should
be
viewed
as
reprehensible
or
indirect
in
any
pejorative
sense.
The
transaction,
as
was
suggested
to
you
previously,
is
not
a
sham
transaction.
The
taxpayer
never
maintained
that
it
had
a
business
purpose
other
than
a
tax
purpose
and
does
not
do
so
at
this
time.
The
transaction
was
not
a
sham.
It
created
the
legal
relations
it
intended
to
create
and
it's
clearly
within
the
words
of
subsection
74(1).
Mrs.
Sullivan
received
no
dividends
whatsoever.
And
the
question
is
whether
or
not
she
is
required
to
pay
tax
on
those
dividends
even
though
she
didn't
receive
them.
It
is
the
taxpayer's
submission
that
the
attribution
rules
apply
and
have
that
effect;
and
in
many,
many
situations
the
application
of
the
attribution
rules
in
different
circumstances—will
give
a
ridiculous
result,
an
apparently
ridiculous
result,
but
this
result
is
because
of
the
words
of
the
Act
and
the
method
of
enforcing
them.
But,
effectively,
she
received
no
dividends.
[Emphasis
added.]
And
for
the
respondent:
The
Minister,
your
Honour,
has
three
basic
submissions.
.
.First
of
all,
in
examining
the
transaction
or
transactions
in
this
matter
and
interpreting
the
legislation,
I
would
ask
your
Honour
to
firstly
look
at
the
substance
of
the
transaction.
.
.to
look
at
the
intention
and
purpose
of
section
74
and
the
mischief
that
that
section
was
aimed
at
prior
to
its
repeal.
The
second
argument
is
that
there
was
an
agency
relationship
in
the
creation
of
and
subsequent
transfer
of
the
shares.
The
third
argument
is
the
intention
of
Parliament
in
section
74
to
prevent
income
splitting.
In
my
submission,
it
admits
of
no
other
possible
purpose.
And
the
Appellant
is
attempting
to
use
section
74
to
split
income
which
is
the
exact
mischief
that
that
section
is
aimed
at
preventing.
And
it's
the
Minister's
submission
that
where
property
is
transferred
but
subsequent
to
the
transfer
something
is
done
to
the
property,
attributes
are
added
to
it,
value
is
injected
into
it,
that
that
changes,
that
somehow
that
no
longer
becomes
the
property
transferred.
.
.
.
The
interposition
of
a
corporation
doesn't
alter
the
substance
of
the
transaction.
A
taxpayer
cannot
add
value
to
transferred
property
and
then
say
that
the
income,
the
income
that
arose
from
the
property
is
from
the
property
transferred.
You
cannot
alter
the
attributes
of
the
property.
What
happened
here,
your
Honor,
is
that
Mrs.
Sullivan
transferred
property
to
her
husband.
He
then
fundamentally
alters
that
property
by
adding
tremendous
value
to
it.
By
the
rollover,
those
shares
are
now
worth
$450,000,
the
one-half,
whereas
before
they
were
worth
$1,000.
The
income
which
results
from
those
shares
is
not
income
from
the
property
transferred,
it
is
income
from
the
operating
company
effectively.
And
really
it
is
income
from
the
value
added
to
the
property,
added
to
the
1,000
shares
originally
owned
by
Mrs.
Sullivan
and
transferred
to
her
husband,
to
which
Mr.
Sullivan
has
added
that
extra
value
after
the
transfer.
It's
clear
that
but
for
the
rollover
and
but
for
the
contributed
surplus,
the
numbered
company
could
never
have
paid
dividends,
and
I
think
that
Mr.
McNair
agreed
with
that
point.
[Emphasis
added.]
Analysis
As
can
be
seen
the
arguments
presented
by
the
parties
concentrated
largely,
on
the
interpretation
and
application
of
section
74
of
the
Act.
The
parties
were
recalled
to
Court
for
the
second
day,
and
comments
requested
regarding
certain
aspects
of
section
85
of
the
Act
also.
I
am
not
persuaded
that
the
respondent's
first
and
second
arguments
above
meet
directly
the
prime
point
of
the
appellant
that
the
transaction
under
review
fits
completely
within
the
confines
of
the
words
of
subsection
74(1)
of
the
Act.
The
first
point
of
counsel
for
the
respondent
is
somewhat
akin
to
an
“object
and
spirit”
argument.
That
might
have
value
in
a
supportive
or
interpretative
way,
but
I
fail
to
see
it
as
effective
as
the
basic
position
in
making
this
assessment.
With
regard
to
counsel's
second
point—an
"agency"
relationship,
there
was
no
evidence
presented
at
the
trial
on
which
I
could
conclude
that
in
her
own
conduct
Mrs.
Sullivan
was
in
that
position.
She
had
independent
consultation,
according
to
her,
and
had
made
no
commitment
to
deal
with
the
shares
of
551360
in
advance,
as
occurred
in
this
appeal.
I
doubt
that
she
was
any
more
aware
of
the
implications
of
the
total
program
than
was
Mr.
Sullivan,
and
she
certainly
followed
advice.
But
I
was
not
persuaded
that
based
on
that
argument
the
entire
proposition
of
the
appellant
could
be
rejected.
The
critical
point
made
by
counsel
for
the
appellant
is
that
at
the
time
the
dividends
were
declared
and
paid
by
551360
to
Mr.
Sullivan,
there
was
no
difference
between
the
1,000
shares
originally
issued
to
Mrs.
Sullivan
for
$1,000
and
sold
to
Mr.
Sullivan
for
the
same
amount,
and
the
1,000
shares
issued
to
Mr.
Sullivan
in
exchange
for
his
5,001
shares
in
Drugs
which
at
the
time
of
exchange
had
a
fair
market
value
of
$900,000.
I
do
not
see
that
the
Minister's
contra
argument
(the
third
above)
is
too
explicit
or
complete,
but
in
essence
the
Minister’s
position
is
that
"something"
must
have
happened
to,
or
been
attributed
to
the
original
1,000
shares
purchased
from
Mrs.
Sullivan
to
reflect
one-half
of
that
$900,000
fair
market
value,
as
I
see
it
a
reference
more
to
section
85
of
the
Act.
As
I
understand
the
appellant's
position,
the
Court
should
hold
that
the
2,000
shares
of
551360
finally
held
by
Mr.
Sullivan
were
identical
shares
in
all
corporate
respects,
and
therefore
equally
eligible
for
any
declaration
of
dividends
by
551360.
The
fact
that
the
attribution
rules
under
section
74
of
the
Act
served
to
split
that
dividend
income
to
the
taxpayer's
advantage,
while
objectionable
to
the
respondent,
should
be
accepted
as
the
legal
and
proper
end
result.
On
the
surface
of
it,
that
appears
to
be
a
sensible
and
tenable
argument.
However,
as
I
see
it,
that
depends
on
the
appellant
demonstrating,
on
the
balance
of
probabilities,
that
the
2,000
shares
of
551360
were
identical
in
all
respects
and
so
entitled
for
purposes
of
the
Act.
Such
a
fine
distinction
between
characteristics
for
income
tax
purposes,
as
contrasted
with
those
for
solely
corporate
purposes,
is
not
a
simple
concept,
and
it
is
for
that
reason
I
have
placed
stress
on
the
application
of
section
85
of
the
Act
in
these
circumstances.
If
indeed
it
can
be
shown
by
the
appellant
that
the
utilization
of
section
85
of
the
Act
did
not
leave
any
distinguishing
marks
on
the
second
1,000
shares
of
551360
issued
to
Mr.
Sullivan,
then
there
would
be
no
valid
reason
to
reject
the
appellant's
proposition.
Counsel
for
the
appellant
agreed
(argument
supra,)
that
there
had
been
value
added
to
the
original
1,000
shares
and
apparently
the
increase
in
the
value
of
$450,000
was
not
disputed.
Counsel
at
the
same
time
took
the
position
that
since
none
of
thee
attributes
had
changed
in
those
particular
1,000
shares,
they
remained
identical
to
the
second
1,000
shares
issued
and
therefore
could
be
treated
no
differently.
I
am
not
quite
sure
that
answers
the
point
at
issue.
It
appears
to
me
that
the
appellant
and
his
advisors
now
wish
to
utilize
the
protection
they
see
in
section
74
of
the
Act—
saying
in
effect
that
the
income
from
the
original
1,000
shares
must
be
considered
for
income
tax
purposes
as
if
they
remained
the
property
of
Mrs.
Sullivan,
while
ignoring
also
for
income
tax
purposes,
any
direct
consequences
which-
arose
out
of
the
use
of
the
section
85
rollover.
That
is
at
the
heart
of
the
matter.
It
was
agreed
that
there
was
little,
if
anything,
in
the
case
law
touching
directly
on
point.
The
significant
part
of
the
Income
Tax
Act
to
be
addressed
in
my
view
is
subsection
85(1)
which
reads
as
it
is
relevant
to
this
appeal:
Where
a
taxpayer
has,
after
May
6,
1974,
disposed
of
any
of
his
property
that
was
a
capital
property
(other
than
real
property,
an
interest
therein
or
an
option
in
respect
thereof,
owned
by
a
non-resident),
a
property
referred
to
in
subsection
59(2),
an
eligible
capital
property
or
an
inventory
(other
than
real
property)
to
a
taxable
Canadian
corporation
for
consideration
that
includes
shares
of
the
capital
stock
of
the
corporation,
if
the
taxpayer
and
the
corporation
have
jointly
so
elected
in
prescribed
form
and
within
the
time
referred
to
in
subsection
(6),
the
following
rules
apply:
(a)
the
amount
that
the
taxpayer
and
the
corporation
have
agreed
upon
in
their
election
in
respect
of
the
property
shall
be
deemed
to
be
the
taxpayer's
proceeds
of
disposition
of
the
property
and
the
corporation's
cost
of
the
property;
While
assets
of
some
form
(capital
property,
inventory,
etc.)
are
the
subject
of
the
transfer
or
disposal
under
section
85
of
the
Act—when
one
speaks
of
a
section
85
"rollover",
the
reference
is
to
the
rolling
into
the
transferee
corporation
of
any
potential
tax
liability
inherent
in
the
asset
which
is
the
subject
of
the
disposal.
The
potential
tax
liability
would
become
a
question
of
immediate
consideration
except
for
the
"election"
provisions
under
section
85.
That
"election"
does
nothing
more
than
to
formally
notify
Revenue
Canada
that
both
the
transferor
and
the
transferee
acknowledge
the
continued
existence
of
the
potential
liability
and
that
the
"consideration
that
includes
shares
of
the
capital
stock
of
the
corporation"
(see
subsection
85(1))
now
is
the
repository
of
that
potential
liability
rather
than
the
former
shares
in
Drugs
held
by
the
transferor.
In
addition,
certain
amounts
which
can
be
used
in
the
eventual
calculation
of
that
liability
are
determined—and
these
amounts
relate
to
“fair
market
value”,
and
"cost
amount".
In
the
instant
appeal,
the
significance
of
this
analysis
is
that
the
"earned
surplus”
of
$744,037
in
Drugs
at
the
time
of
transfer
was
the
major
reference
point
for
the
determination
of
the
$900,000
“fair
market
value"
figure
used
in
the
"election
form".
There
was
no
evidence
which
would
show
that
the
5,001
shares
of
Drugs
transferred
by
Mr.
Sullivan
could
have
a
value
much
different
than
the
nominal
$53,
without
taking
into
account
the
“earned
surplus”
above.
The
appellant
recognized
the
inclusion
of
the
"retained
earnings”
in
the
calculation
of
the
$900,000—see
Exhibit
A-6
above.
The
"retained
earnings"
which
had
formed
the
basis
for
the
“fair
market
value”
calculation
of
the
5,001
shares
of
Drugs
when
they
were
owned
by
Mr.
Sullivan,
now
formed
the
basis
for
any
capital
gain
built
into
the
specific
shares
of
551360
received
by
the
transferor
as
consideration.
The
transfer
by
Mr.
Sullivan
of
his
shares
in
Drugs
to
551360
in
exchange
for
the
issue
by
551360
of
1,000
treasury
shares
of
its
own
stock
to
him,
did
not
of
itself
transfer
any
of
the
assets
of
Drugs
to
551360.
But
it
did
transfer
to
551360
any
claim
formerly
held
by
the
transferor
against
the
equity
or
earned
surplus
in
Drugs
to
that
point,
to
the
corporation
551360.
Mr.
Sullivan
accepted
as
full
consideration
for
the
value
of
the
5,001
shares
in
Drugs,
including
such
equity,
the
1,000
new
shares
of
551360
but
the
exchange
itself
did
not
alter
or
dilute
in
any
way
the
“equity”
or
“net
worth"
of
Drugs.
As
noted
earlier
in
the
exhibits
referenced,
there
were
no
"assets
acquired”
by
551360
from
Drugs
as
part
of
the
section
85
rollover.
The
section
85
rollover
being
examined
here
was
not
from
Drugs
to
551360,
but
from
the
appellant
Mr.
Sullivan
personally
to
551360.
It
covered
shares
of
Drugs,
owned
by
the
appellant,
not
assets
of
the
corporation.
I
do
not
want
to
suggest
that
there
is
anything
odious
about
the
events
under
review
in
these
appeals
by
referring
to
a
more
“normal”
section
85
transaction.
But
I
believe
it
is
fair
to
say
that
in
a
normal
section
85
use,
some
different
shares
(often
preference
shares)
would
be
taken
back
by
the
transferor,
which
shares
at
some
future
time
might
be
sold
or
redeemed
to
provide
him
with
the
realization
of
the
capital
gain
contained
in
the
shares.
As
the
respondent
sees
it,
the
dividends
from
Drugs
were
used
as
a
direct
"flow-
through"
using
551360
to
Mr.
Sullivan.
As
noted
earlier,
even
that
in
principle
the
respondent
does
not
seem
to
regard
as
improper.
It
is
only
the
splitting
of
the
dividends
from
551360
to
which
the
Minister
objects.
I
recognize
that
since
Mr.
Sullivan
no
longer
personally
owned
the
shares
of
Drugs,
he
would
have
been
in
a
very
vulnerable
position
financially
without
the
ownership
or
control
of
551360,
but
that
is
not
in
issue.
The
legal
and
physical
characteristics
of
the
second
1,000
shares
of
551360,
including
entitlement
to
dividends
from
the
"retained
earnings"
or
"earned
surplus"
of
that
company
are
the
same
as
the
legal
and
physical
characteristics
of
the
first
1,000
shares
issued.
The
question
is,
however,
do
the
dividends
from
Drugs
“flow
through"
to
551360
unimpaired
by
the
provisions
of
the
Act
and
reach
the
"earned
surplus”
of
551360
so
as
to
make
them
available
for
such
equivalent
distribution.
I
am
not
persuaded
that
the
dividends
received
from
Drugs
can
be
reflected
in
the
accounts
of
551360
without
recognizing
and
highlighting
the
special
nature
of
the
dividends
which
arise
out
of
the
use
of
section
85
of
the
Act.
No
segregation
was
necessary
until
the
dividends
were
paid
from
Drugs—which
dividends
effectively
depleted
the
"earned
surplus"
of
Drugs.
That
"earned
surplus"
in
Drugs
had
attached
to
it,
by
virtue
of
the
section
85
rollover
certain
characteristics
which
were
recognized
in
the
notice
of
appeal
of
Mr.
Sullivan
as
follows:
That
any
difference
between
the
purchase
price
of
the
shares
of
Hugh
Sullivan
Drugs
Ltd.
and
the
specified
consideration
of
$52.98
in
shares
of
551360
Ontario
Ltd.
was
to
be
recorded
on
the
books
of
551360
Ontario
Ltd.
as
contributed
surplus.
[Emphasis
added.]
Whether
the
term
"contributed
surplus"
should
be
regarded
as
anatomically
correct,
was
not
argued
at
the
trial,
and
some
other
identification
could
be
just
as
descriptive.
The
term
“contributed
surplus"
may
however
be
quite
appropriate,
since
it
does
at
least
indicate
that
the
source
of
the
funds
has
some
particular
identity.
However
characterized,
the
point
is
that
the
dividends
received
by
551360
do
not
become
“surplus
on
hand"
for
equal
distribution
to
all
shareholders,
even
all
common
shareholders,
and
not
necessarily
just
because
the
common
shares
are
all
held
by
one
party.
The
critical
fact
is
that
the
full
consideration
for
the
5,001
shares
of
Drugs
transferred
by
Mr.
Sullivan
to
551360
must
be
accounted
for
in
his
hands,
under
whatever
scheme
for
payment
he
has
selected.
A
very
crude
analogy
would
be
to
look
at
(or
through)
the
transactions
as
similar
to
items
of
"accrued
interest",
“interest
payable”,
and
"interest
paid”,
to
make
the
matter
somewhat
less
complex.
Obviously,
one
does
not
extinguish
the
"accrued
interest"
on
one
set
of
obligations
by
paying
a
part
of
it
to
the
holder
of
another
set
of
obligations
or
to
a
party
holding
no
obligations
at
all.
It
is
my
view
that
551360
because
it
was
used
as
a
vehicle
in
this
section
85
rollover
and
election
in
these
circumstances,
could
only
use
the
dividends
received
from
Drugs
for
the
benefit
of
the
second
1,000
shares
issued.
Drugs
declared
dividends
of
$660,000
to
551360
in
fiscal
1983,
and
a
further
amount
of
$132,000
in
fiscal
1984—thereby
directly
reducing
the
"retained
earnings”
of
Drugs
which
was
the
support
for
the
“capital
gain"
inherent
in
Mr.
Sullivan’s
second
1,000
shares
of
551360.
I
am
satisfied
that
the
evidence
and
testimony
lead
to
this
result,
but
as
some
form
of
support
for
this
conclusion
I
would
make
reference
to
the
following
extracts
from
noted
material
on
the
subject.
A.
The
Taxation
of
Corporate
Reorganizations
CTJ,
Vol.
36,
no.
5,
Sept./Oct.
1988
“Limitations
to
Section
85—General
Rule"
(Douglas
S.
Ewens,
David
Y.
Timbrell
and
Richard
C.
Rohde)
-
Subsection
85(1)
of
the
Act
is
intended
as
a
mechanism
to
allow
for
the
deferral
of
tax
on
the
conveyance
of
property
to
a
taxable
Canadian
corporation,
provided
that
an
appropriate
election
is
promptly
filed
and
that
the
consideration
received
for
the
property
transferred
includes
shares
of
the
transferee
corporation.
-
To
accomplish
a
so-called
rollover
of
the
inherent
tax
liability
under
section
85,
both
parties
must
agree
to
an
elected
amount
within
a
permitted
range
for
each
property
that
will
be
the
transferor's
proceeds
of
disposition,
and
the
transferee's
cost.
The
cost
of
the
consideration
received
by
the
transferor
will
be
deemed
to
be
equal
to
the
aggregate
elected
amounts
for
the
properties
transferred.
If
both
shares
and
non-share
consideration
are
received
(that
is
cash
and
debt),
the
nonshare
consideration
will
take
on
a
tax
cost
equal
to
its
fair
value
at
the
time
of
the
transfer.
-
It
is
important
to
note
that,
since
the
accrued
gain
on
the
transferred
property
is
built
into
the
shares
received
by
the
transferor
with
no
corresponding
adjustment
to
the
cost
base
for
the
property
acquired
by
the
transferee
corporation,
an
element
of
double
taxation
can
result;
once
on
the
disposition
of
the
asset
by
the
transferee
corporation
and
again
on
the
disposition
of
the
shares
by
the
transferor.
-
The
above
comments
are
intended
as
a
summary
of
some
of
the
limitations
to
section
85
and
some
of
the
traps
to
be
considered;
this
summary,
however,
is
by
no
means
exhaustive.
In
addition,
it
is
always
important
to
consider
the
sales
tax'
capital
tax,
and
accounting
implications
before
proceeding.
B.
"The
Pitfalls
of
Section
85"
CA
Magazine,
Vol.
117,
no.
12,
Dec.
1984
(Clifford
R.
Plume)
-
Because
shares
must
be
received
for
assets
transferred
under
Section
85.
the
determination
of
the
number
and
type
will
depend
on
whether
the
transferor
is
the
sole
shareholder,
or
whether
the
indirect
gift
rule
could
apply
to
the
transaction.
A
major
pitfall
can
occur
in
the
situation
where
a
transferor
transfers
property
having
accrued
gains,
to
a
corporation
that
has
only
common
shares
authorized
at
a
time
when
other
family
members
own
some
of
the
common
shares.
As
stated
earlier,
where
Section
85(1)
(e.2)
is
of
concern,
fair
market
value
of
the
total
consideration
becomes
important.
Usually,
non-share
consideration
is
received
by
the
transferor
up
to
the
amount
of
the
adjusted
cost
base
of
the
assets
transferred
to
the
corporation,
and
preference
shares
are
received
for
the
difference
between
the
fair
market
value
of
the
property
transferred
and
the
adjusted
cost
base,
which
is
the
elected
amount.
-
As
mentioned
earlier,
a
major
problem
arises
if
the
company's
only
authorized
shares
are
common
shares
and
assets
are
transferred
to
the
company
at
a
time
when
other
family
members
own
some
of
the
common
shares.
In
my
view,
the
transaction
timing
becomes
crucial.
The
articles
of
incorporation
must
be
amended
before
the
asset
transfer
to
provide
for
a
class
or
classes
of
preference
shares
that
will
have
attached
to
them
sufficient
rights
and
conditions
to
provide
the
required
fair
market
value.
Careful
drafting
of
the
rights
and
conditions
attaching
to
those
preference
shares
is
mandatory
to
ensure
that
problems
will
not
arise
relating
to
the
indirect
gift
rule.
-
One
of
the
down-side
risks
in
using
Section
85
is
the
inherent
double
taxation
of
the
same
gain
-
once
in
the
hands
of
the
transferor
and
again
in
that
of
the
corporation.
Consideration
should,
therefore,
be
given
to
what
future
steps
could
be
taken
to
eliminate,
or
at
least
minimize,
the
double
taxation.
-
The
solution
to
that
situation
is
to
take
back
on
the
transfer
a
different
class
of
shares
or
to
take
back
a
sufficient
number
of
shares
of
the
same
class
that
bring
about
the
appropriate
results
when
dispositions
occur
in
stages.
C.
“Accounting
Section
85”
CA
Magazine,
Vol.
114,
no.
7,
July
1981
(James
M.
Sylph,
and
Eric
G.
Percival)
-
Most
income
tax
systems
that
tax
capital
gains
and
allow
the
deduction
of
capital
losses
permit
share
exchanges
and
transfers
of
property
between
corporations
and
their
shareholders
or
between
related
corporations
without
immediate
recognition
of
the
resulting
gains
or
losses
for
income
tax
purposes.
The
rationale
is
to
prevent
undue
tax
burdens
on
corporate
reorganizations,
takeovers,
intercorporate
transfers
of
assets
and
other
transactions
that
occur
frequently
between
corporations
and
their
shareholders
in
the
course
of
furthering
their
business
activities.
This
is
the
way
it
works
in
Canada
as
well.
-
The
now
infamous
tax
reform
of
January
1,
1972,
introduced
a
provision
in
the
Income
Tax
Act,
under
the
rules
of
Section
85,
to
enable
a
deferral
of
tax
that
might
otherwise
be
payable
on
sales
or
transfers
of
various
assets
that
must
normally
be
reported
at
fair
market
value.
The
rollover
is
available
when
a
taxpayer
(an
individual,
partnership
or
corporation)
transfers
the
qualifying
property
to
a
Canadian
corporation
for
a
consideration
(including
shares
of
that
corporation)
and
both
parties
jointly
elect
that,
for
tax
purposes
the
transaction
takes
place
at
an
agreed
amount.
Section
85
provides
a
range
within
which
such
an
election
may
take
place.
Generally,
the
untaxed
gain
must
be
represented
wholly
or
in
part
by
shares
of
the
purchasing
corporation,
with
the
non-share
consideration
(cash,
demand
note,
etc.)
normally
equal
to
the
tax
value
of
the
assets
to
the
vendor.
D.
"Transferring
shares
of
private
corporations
need
not
be
so
taxing"
CA
Magazine,
Vol.
113,
no.
5,
May
1980
(Alan
M.
Schwartz)
-
Enough
time
has
now
passed
since
Valuation
Day
for
taxpayers
to
begin
considering
whether
a
substantial
capital
gain
and
resulting
tax
liability
may
arise
when
they
transfer
shares
of
a
non-public
corporation.
To
many,
this
will
be
a
distasteful
thought
because
their
capital
gains
are
partly
a
reflection
of
the
inflationary
increases
in
value
that
have
occurred
since
1971.
The
thought
becomes
positively
abhorrent
where
the
transfer
involves
transferring
a
family
business
from
one
generation
to
another.
-
Under
a
typical
Section
85
freeze,
a
parent
transfers
his
or
her
shares
of
an
operating
corporation
("Opco")
to
a
new
holding
corporation
("Holdco")
and
takes
back
preference
shares
equal
in
value
to
the
transferred
Opco
shares.
The
children
subscribe
for
the
common
shares
of
Holdco,
paying
for
them
a
nominal
price.
To
ensure
the
rollover
benefits
to
the
parent,
however,
it
is
imperative
that
the
Holdco
preference
shares
taken
back
have
a
fair
market
value
equal
to
the
shares
of
Opco.
-
Also,
if
the
parent
is
elderly,
a
Section
85
freeze
may
give
rise
to
double
taxation.
It
happens
this
way.
First.
at
the
time
of
death,
the
parent
is
deemed
to
receive
proceeds
of
disposition
equal
to
the
fair
market
value
of
Holdco's
preference
shares.
This
will
trigger
a
capital
gain
equal
to
the
difference
between
such
proceeds
and
the
cost
base
to
the
parent
of
the
preference
shares—
generally
the
cost
base
to
the
parent
of
the
Opco
common
shares
transferred
to
Holdco.
Then
the
second
level
of
tax
occurs,
when
Holdco
sells
the
Opco
shares,
realizing
a
capital
gain
equal
to
the
difference
between
the
sale
price
and
the
cost
to
Holdco
under
Section
85
-
which
is
generally
the
cost
base
to
the
parent
of
the
Opco
shares
he
or
she
transferred
to
Holdco.
-
Specifically,
the
taxpayer
transfers
shares
of
a
family
business
(Opco)
to
a
holding
company
(Holdco).
This
is
done
pursuant
to
Section
85
of
the
Income
Tax
Act
so
that
no
capital
gain
will
arise
on
the
transfer.
Opco
would
then
pay
a
dividend
equal
to
its
retained
earnings
to
Holdco,
which
would
receive
it
tax-free
as
an
intercorporate
dividend.
Holdco
would
then
sell
the
Opco
shares
to
the
child
or
third
party.
-
The
result
of
such
a
procedure
is
that
the
capital
gain
is
replaced
by
an
intercorporate
dividend
which
is,
as
mentioned
above,
received
tax-free
by
Holdco.
Revenue
Canada
has
stated
that,
as
long
as
the
amount
of
the
dividend
does
not
exceed
Opco's
“post-1971
taxed
retained
earnings,”
it
will
not
invoke
Section
55
(i.e.,
the
section
dealing
with
artificial
reduction
of
capital
gains).
Tax
retained
earnings
is
defined
by
Revenue
Canada
to
be
retained
earnings
computed
in
accordance
with
generally
accepted
accounting
principles
(GAAP).
-
Thus,
flushing
out
dividends
should
continue
to
be
available
as
a
means
of
reducing
capital
gains,
but
only
to
the
extent
that
a
dividend
does
not
exceed
post-1971
taxed
retained
earnings
or
Part
IV
tax.
-
For
example,
if
the
Opco
shares
have
a
paid-up
capital
of
$100
and
a
fair
market
value
of
$100,000,
Holdco
shares
would
be
issued
with
an
aggregate
par
value
of
$100.
The
difference
between
$100,000
and
the
$100
($99,900)
will
be
shown
as
contributed
surplus.
-
The
dividend
paid
to
Holdco
can,
as
mentioned,
be
lent
to
Opco.
As
the
loan
is
paid
off,
the
money
may
be
invested
by
Holdco
and
used
as
a
source
of
retirement
income
for
the
parent
and
his
or
her
family.
E.
Canadian
Tax
Foundation
Corporate
Tax
Management
Conference
1978,
page
200
(Howard
J.
Kellough)
-
The
ability
to
split
income
is
one
of
the
natural
consequences
of
owning
shares
in
a
corporation.
Reference
has
been
made
above
to
the
attribution
problems
associated
with
this
concept.
It
was
also
observed
that
the
$1,000
interest
and
dividend
deduction
under
section
110.1
will
be
lost
where
dividends
are
received
from
a
non-arm's
length
holding
company
as
opposed
to
being
received
directly
from
an
operating
corporation
with
which
the
individual
may
otherwise
be
at
arm's
length.
-
The
labyrinth
of
problems
confronting
the
non-arm's
length
taxpayer
suggests
that
he
should
probably
consider
acquiring
the
shares
in
a
holding
corporation,
effect
the
financing
through
the
holding
corporation,
then
proceed
with
either
an
amalgamation
or
a
winding-up.
-
This
arrangement
is
similar
to
the
direct
corporate
buy-out,
except
that
the
shares
owned
by
Father
are
first
transferred
to
a
holding
company
and
the
corporate
purchase
is
between
the
holding
company
and
Opco.
In
order
to
put
this
arrangement
in
place,
Father
would
transfer
his
shares
in
Opco
to
either
an
existing
or
a
newly
incorporated
corporation
under
subsection
85(1).
Common
shareholders
of
Holdco
could
be
either
Father
alone,
or
Father
and
other
members
of
his
family,
such
as
his
wife.
The
common
shares
of
Opco
could
be
converted
into
fixed
value
preference
shares
under
section
86.
The
intended
common
shareholders
would
subscribe,
either
directly
or
through
their
own
holding
companies,
for
common
shares
of
a
new
class
in
Opco.
Father
would
cause
his
preference
shares
to
be
redeemed
from
time
to
time
from
the
earnings
of
Opco.
Finally,
the
proceeds
of
redemption
either
could
be
re-invested
by
Holdco
in
Opco
or
elsewhere
or
used
to
pay
taxable
dividends
to
Holdco's
shareholders.
-
Where
section
84.1
does
not
apply,
the
consideration
given
by
Holdco
on
the
subsection
85(1)
transfer
by
Father
of
his
Opco
shares
can
be
represented
by
nonshare
consideration
and
can
be
repaid
to
Father
as
a
return
of
capital
before
dividends
of
the
shares
(representing
the
consideration
given
for
the
deferred
gain
element
of
the
Opco
shares)
are
redeemed.
-
The
ability
to
return
capital
in
this
manner
would
not
be
available
if
the
consideration
received
by
Father
comprised
only
one
class
of
shares.
This
is
because
the
adjusted
cost
base
would
be
distributed
pro
rata
among
all
shares
and
the
redemption
thereof
would
give
rise
to
a
partial
return
of
capital
and
either
a
capital
gain
or
deemed
dividend,
depending
on
the
extent
of
the
paid-up
capital
of
the
shares.
A
pure
return
of
capital
could
be
effected,
however,
if
two
classes
of
shares
are
issued
by
Holdco
and
the
class
of
preference
shares
represent
consideration
equal
in
value
to
the
adjusted
cost
base
of
the
Opco
shares
(and
have
an
equivalent
paid-
up
capital)
and
the
common
shares
constituted
consideration
for
the
gain
deferred.
[Emphasis
added.]
I
do
not
suggest
that
everything
in
the
above
quotations
can
be
applied
directly
to
this
case,
but
the
general
parameters,
and
risks
are
outlined.
I
would
make
particular
reference
to
the
following:
From
A.
-
the
accrued
gain
on
the
transferred
property
is
built
into
the
shares
received
by
the
transferor.
.
.
From
B.
-
one
of
the
downside
risks
in
using
section
85
is
the
inherent
double
taxation
of
the
same
gain—once
in
the
hands
of
the
transferor
and
again
in
that
of
the
corporation.
Consideration
should,
therefore,
be
given
to
what
future
steps
could
be
taken
to
eliminate,
or
at
least
minimize,
the
double
taxation.
-
The
solution
to
that
situation
is
to
take
back
on
the
transfer
a
different
class
of
shares
or
to
take
back
a
sufficient
number
of
shares
of
the
same
class
that
bring
about
the
appropriate
results
when
dispositions
occur
in
stages.
From
D.
-
Specifically,
the
taxpayer
transfers
shares
of
a
family
business
(Opco)
to
a
holding
company
(Holdco).
This
is
done
pursuant
to
Section
85
of
the
Income
Tax
Act
so
that
no
capital
gain
will
arise
on
the
transfer.
Opco
would
then
pay
a
dividend
equal
to
its
retained
earnings
to
Holdco,
which
would
receive
it
tax-free
as
an
intercorporate
dividend.
Holdco
would
then
sell
the
Opco
shares
to
the
child
or
third
party.
-
The
result
of
such
a
procedure
is
that
the
capital
gain
is
replaced
by
an
intercorporate
dividend
which
is,
as
mentioned
above,
received
tax-free
by
Holdco.
-
Thus,
flushing
out
dividends
should
continue
to
be
available
as
a
means
of
reducing
capital
gains,
but
only
to
the
extent
that
a
dividend
does
not
exceed
post-1971
taxed
retained
earnings
or
Part
IV
tax.
-
For
example,
if
the
Opco
shares
have
a
paid-up
capital
of
$100
and
a
fair
market
value
of
$100,000,
Holdco
shares
would
be
issued
with
an
aggregate
par
value
of
$100.
The
difference
between
$100,000
and
the
$100
($99,900)
will
be
shown
as
contributed
surplus.
[Emphasis
added.]
Summary
It
is
my
appreciation
of
the
testimony
that
the
appellant
and
his
advisors
did
not
take
into
account
fully
the
importance
of
the
phrase
from
"A"
above—the
Taxation
of
Corporate
Reorganizations,
that
"accrued
gain
on
the
transferred
property
is
built
into
the
shares
received
by
the
transferor"
which
I
believe
to
be
quite
an
accurate
representation
of
the
effect
of
the
section
85
rollover
and
which
is
consistent
with
the
analysis
of
the
matter
above.
No
provision
was
made
by
any
other
shares
or
class
of
shares
for
the
required
fair
market
value
(See
"B"
above—CA
Magazine,
Vol.
117,
no.
12,
December
1984).
As
I
see
it
the
critical
1,000
new
shares
therefore
became
axiomatically
a
form
of
common
shares
distinct
and
different
from
the
original
1,000
shares.
As
at
least
further
partial
support
for
this
conclusion
I
would
again
refer
to
section
84
of
the
Act—
specifically
subsection
84(4)—wherein
the
term
"a
dividend
on
a
separate
class
of
shares
comprising
the
shares
so
redeemed"
is
used.
I
know
that
reference
is
to
a
different
type
of
transaction,
and
deals
with
a
"deeming
provision".
However,
I
do
not
find
it
unrealistic
that
in
the
circumstances
of
this
case,
the
appellant
has
accomplished
that
which
I
contend
in
this
judgment,
rather
than
managing
to
subordinate
the
provisions
of
section
85
of
the
Act
to
the
provisions
of
section
74
of
the
Act,
as
he
asserts.
I
have
certainly
not
heard
from
the
appellant
a
cogent
argument
which
would
move
the
funds
at
issue
from
"contributed
surplus"
(as
it
was
termed
above)
with
the
attendant
restrictions,
to
some
form
of
"earned
surplus"
for
unlimited
utilization
by
551360.
It
might
well
be
argued
that
some
questions
might
have
been
raised
by
Revenue
Canada
at
the
time
of
filing
of
Exhibit
A-7
(the
election
form),
rather
than
at
the
assessment
stage,
but
that
is
not
the
issue
here.
In
what
manner
this
conundrum,
set
up
by
the
appellant's
advisors,
could
or
should
be
finally
resolved
is
not
for
me
to
decide.
The
sole
issue
for
this
Court
is
whether
any
of
the
dividends
declared
and
paid
by
551360
out
of
the
funds
received
by
dividend
from
Drugs,
come
under
the
attribution
rules
of
section
74
of
the
Act,
and
they
do
not.
The
attribution
rules
from
section
74
do
not
even
arise,
the
matter
resting
at
the
stage
of
the
results
of
the
section
85
rollover.
The
appeals
are
dismissed.
Appeals
dismissed.